Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
Asymptomatic men without pain due to prostate cancer progressing with metastatic CRPC after treatment with combination or sequential ADT + Abi will be treated on a randomized, open label study to determine if sequential treatment with high dose T and Enza will improve primary and secondary objectives vs. continuous Enza as standard therapy.
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Check if you qualify for this prostate cancer clinical trial in Seattle, WA
If you're searching for prostate cancer treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.